12th Annual Drug Discovery for Neurodegeneration Conference
In-Person Event
Feb 04 - 06, 2018
Arlington, Virginia, USA
OVERVIEW
12th Annual Drug Discovery for Neurodegeneration Conference is organized by Alzheimers Drug Discovery Foundation (ADDF) and will be held during Feb 04 - 06, 2018 at The Ritz-Carlton, Pentagon City, Arlington, Virginia, United States of America.
The target audience for this medical event for Neurologists, Psychiatrists, Delegates at the Annual Drug Discovery for Neurodegeneration Conference are drawn from academia, industry, associations/societies, government and media.
Conference Objectives are :
• Train a cadre of interdisciplinary scientists in the principles of drug discovery for neurodegenerative disease.
• Provide a platform to exchange ideas, knowledge and resources about drug discovery for neurodegenerative disease.
• Stimulate pre-clinical research in the discovery and testing of novel compounds aimed at the prevention and treatment of neurodegenerative disease.
• Build public-private partnerships that will accelerate drug discovery for neurodegenerative disease.
What Will You Learn?
• Challenges and opportunities in academic drug discovery
• Fundamentals of medicinal chemistry relevant to drug discovery for neurodegenerative diseases Newest trends in assay development and high throughput screening (HTS)
• Go-no-go criteria for preclinical development, including pharmacokinetic behavior of candidate compounds, aqueous solubility, blood-brain barrier permeability, preliminary safety, and manufacturing issues
• Study design considerations for animal model experiments
• Biologics for challenging CNS targets and strategies to optimize brain delivery
• Requirements for an Investigational New Drug (IND) application
• Commercialization strategies for developing science into products
• Best practices for working with tech transfer offices, managing intellectual property, and the role of funding organizations
• Funding & resources for preclinical therapeutics development for neurological disorders
Additional details will be posted as soon as they are available.
The target audience for this medical event for Neurologists, Psychiatrists, Delegates at the Annual Drug Discovery for Neurodegeneration Conference are drawn from academia, industry, associations/societies, government and media.
Conference Objectives are :
• Train a cadre of interdisciplinary scientists in the principles of drug discovery for neurodegenerative disease.
• Provide a platform to exchange ideas, knowledge and resources about drug discovery for neurodegenerative disease.
• Stimulate pre-clinical research in the discovery and testing of novel compounds aimed at the prevention and treatment of neurodegenerative disease.
• Build public-private partnerships that will accelerate drug discovery for neurodegenerative disease.
What Will You Learn?
• Challenges and opportunities in academic drug discovery
• Fundamentals of medicinal chemistry relevant to drug discovery for neurodegenerative diseases Newest trends in assay development and high throughput screening (HTS)
• Go-no-go criteria for preclinical development, including pharmacokinetic behavior of candidate compounds, aqueous solubility, blood-brain barrier permeability, preliminary safety, and manufacturing issues
• Study design considerations for animal model experiments
• Biologics for challenging CNS targets and strategies to optimize brain delivery
• Requirements for an Investigational New Drug (IND) application
• Commercialization strategies for developing science into products
• Best practices for working with tech transfer offices, managing intellectual property, and the role of funding organizations
• Funding & resources for preclinical therapeutics development for neurological disorders
Additional details will be posted as soon as they are available.
KEY DATES
04 Feb, 2018
Event Start Date
06 Feb, 2018
Event End Date
SPECIALITIES
NeurologyPsychiatrySUGGESTED HOTELS
CONFERENCE VENUE
The Ritz-Carlton, Pentagon CityRELATED CONFERENCES & LIVE WEBINARS
Quick Links